A detailed history of Morningstar Investment Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Morningstar Investment Services LLC holds 9,874 shares of ABBV stock, worth $1.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,874
Previous 8,165 20.93%
Holding current value
$1.78 Million
Previous $1.38 Million 39.35%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $280,002 - $340,654
1,709 Added 20.93%
9,874 $1.92 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $176,460 - $206,066
1,140 Added 16.23%
8,165 $1.38 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $586,379 - $668,124
-3,669 Reduced 34.31%
7,025 $1.27 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $772,761 - $870,311
5,616 Added 110.59%
10,694 $1.66 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $298,707 - $345,797
2,236 Added 78.68%
5,078 $773,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $85,866 - $106,855
648 Added 29.54%
2,842 $378,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $317,274 - $365,388
2,194 New
2,194 $349,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $7,649 - $8,774
57 Added 3.09%
1,903 $285,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $5.48 Million - $6.97 Million
-39,823 Reduced 95.57%
1,846 $284,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $420,224 - $521,380
3,184 Added 8.27%
41,669 $6.8 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $185,209 - $234,343
1,724 Added 4.69%
38,485 $5.21 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $85,332 - $96,865
802 Added 2.23%
36,761 $3.99 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $143,611 - $159,991
1,365 Added 3.95%
35,959 $4.04 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $14,117 - $15,541
-138 Reduced 0.4%
34,594 $3.69 Million
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $434,646 - $586,818
-5,400 Reduced 13.46%
34,732 $3.72 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $163,229 - $191,577
-1,900 Reduced 4.52%
40,132 $3.49 Million
Q2 2020

Jul 30, 2020

BUY
$73.37 - $98.18 $2.75 Million - $3.68 Million
37,532 Added 834.04%
42,032 $4.05 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $290,250 - $440,055
4,500 New
4,500 $339,000
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $220,407 - $245,024
-2,479 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $10,581 - $14,169
-115 Reduced 4.43%
2,479 $235,000
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $48,004 - $52,640
-536 Reduced 17.12%
2,594 $251,000
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $218,630 - $279,258
3,130
3,130 $278,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Morningstar Investment Services LLC Portfolio

Follow Morningstar Investment Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.